Skip to main content

Reimbursement Rate Updates for COVID-19 Monoclonal Antibody Therapy Procedure Codes M0247 and Q0247 Effective May 26, 2021

Last updated on 7/1/2021

Starting June 24, 2021, for dates of service on or after May 26, 2021, the reimbursement rates for COVID-19 Monoclonal Antibody Therapy procedure codes M0247 and Q0247 will be updated for Texas Medicaid and the Children with Special Health Care Needs (CSHCN) Services Program.

To view the updates, click COVID-19 Monoclonal Antibody Therapy Procedure Codes M0247 and Q0247.

Affected claims, if any are identified, will be reprocessed. Providers are not required to appeal the claims unless they are denied for additional reasons after the claims reprocessing is completed.

For more information, call the TMHP Contact Center at 800-925-9126 or the TMHP-CSHCN Services Program Contact Center at 1-800-568-2413.